Semaglutide in medical therapy
US12029779B2 · kind B2 · utility
1Cited by
7References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2020 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | Apr 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to semaglutide for use in weight management.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.